<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Child Neurology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Child Neurology</journal-title><trans-title-group xml:lang="ru"><trans-title>Русский журнал детской неврологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2073-8803</issn><issn publication-format="electronic">2412-9178</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">364</article-id><article-id pub-id-type="doi">10.17650/2073-8803-2021-16-1-2-69-75</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>CLINICAL OBSERVATIONS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ НАБЛЮДЕНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Developmental encephalopathy and epilepsy associated with a heterozygous de novo mutation in the IRF2BPL gene: a case report</article-title><trans-title-group xml:lang="ru"><trans-title>Энцефалопатия развития с эпилепсией вследствие гетерозиготной de novo мутации в гене IRF2BPL: клинический случай</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8286-0407</contrib-id><name-alternatives><name xml:lang="en"><surname>Lyukshina</surname><given-names>N. G.</given-names></name><name xml:lang="ru"><surname>Люкшина</surname><given-names>Н. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>43 Leningradskaya St., Tolyatti 445020</p></bio><bio xml:lang="ru"><p><bold>Наталья Геннадьевна Люкшина</bold>  </p><p>445020 Тольятти, ул. Ленинградская, 43</p></bio><email>neurologist@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0980-2638</contrib-id><name-alternatives><name xml:lang="en"><surname>Sharkov</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Шарков</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>2 Taldomskaya St., Moscow 125412</p><p>8/5 Podolskoe Shosse, Moscow 115093</p></bio><bio xml:lang="ru"><p>125412 Москва, ул. Талдомская, 2</p><p>115093 Москва, Подольское шоссе, 8, корп. 5</p></bio><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tolmacheva</surname><given-names>E. N.</given-names></name><name xml:lang="ru"><surname>Толмачева</surname><given-names>Е. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>8/5 Podolskoe Shosse, Moscow 115093</p></bio><bio xml:lang="ru"><p>115093 Москва, Подольское шоссе, 8, корп. 5</p></bio><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">MIDEAL LLC</institution></aff><aff><institution xml:lang="ru">ООО «МИДЕАЛ»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Department of Psychoneurology and Epileptology, Y.E. Veltishev Research and Clinical Institute for Pediatrics, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">Отдел психоневрологии и эпилептологии НИКИ педиатрии им. Ю.Е. Вельтищева ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.Н. Пирогова» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Medical and Genetic Center “Genomed”</institution></aff><aff><institution xml:lang="ru">Медико-генетический центр «Геномед»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2021-04-15" publication-format="electronic"><day>15</day><month>04</month><year>2021</year></pub-date><volume>16</volume><issue>1-2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>69</fpage><lpage>75</lpage><history><date date-type="received" iso-8601-date="2021-07-30"><day>30</day><month>07</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-07-30"><day>30</day><month>07</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, ABV-Press</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, АБВ-пресс</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">ABV-Press</copyright-holder><copyright-holder xml:lang="ru">АБВ-пресс</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://rjdn.abvpress.ru/jour/about/editorialPolicies</ali:license_ref></license></permissions><self-uri xlink:href="https://rjdn.abvpress.ru/jour/article/view/364">https://rjdn.abvpress.ru/jour/article/view/364</self-uri><abstract xml:lang="en"><p>Developmental encephalopathy with epilepsy or epileptic encephalopathy, associated with a heterozygous mutation in the <italic>IRF2BPL </italic>gene, is a rare severe disorder. It’s manifested by developmental delay or regression of skills until or after epilepsy onset. Patients have a specific facial phenotype, movement disorders with dystonia and choreoathetosis, ataxia, dysarthria, dysmetria, and dysdiadochokinesis. Epilepsy is a common manifestation of the disease (around 70 % of cases), from the age of 6 months to 26 years. Semiology of seizures is vary, including infantile spasms, myoclonic, tonic or clonic seizures with nonspecific electroencephalographic changes. magnetic resonance imaging shows normal brain development at an early age and cortical and cerebellar atrophy developing over time. The authors present a clinical case describing a patient with a causative de novo variant (c.2152delT) in the <italic>IRF2BPL </italic>gene in Russia.This patient was included to common table in an article entitled “<italic>De novo </italic>truncating variants in the intronless <italic>IRF2BPL </italic>are responsible for developmental epileptic encephalopathy” (DOI: 10.1038/s41436-018-0143-0).</p></abstract><trans-abstract xml:lang="ru"><p>Энцефалопатия развития с эпилепсией или эпилептической энцефалопатией, ассоциированная с гетерозиготной мутацией в гене <italic>IRF</italic><italic>2BPL</italic>, является редким тяжелым заболеванием, которое характеризуется остановкой приобретения новых навыков или регрессом уже сформированных в сочетании с эпилепсией с дебютом приступов до или после первых проявлений задержки развития. пациенты имеют специфический лицевой фенотип, двигательные нарушения с дистонией и хореоатетозом, а также такие нарушения, как атаксия, дизартрия, дисметрия и дисдиадохокинез. Эпилепсия выступает частым проявлением заболевания (примерно в 70 % случаев) начиная с возраста от 6 мес до 26 лет. Описана различная семиология приступов, включая инфантильные спазмы, миоклонические, тонические или клонические приступы с неспецифическими изменениями на электроэнцефалограмме. Магнитно-резонансная томография показывает нормальное развитие головного мозга в раннем возрасте с формированием корковой и мозжечковой атрофии с течением времени. Авторы представляют клинический случай пациентки с установленной каузативной <italic>de</italic><italic> novo</italic><italic> </italic>мутацией (c.2152delT) в гене <italic>IRF</italic><italic>2BPL</italic>.Эта пациентка была включена в общую таблицу в статье “<italic>De novo </italic>truncating variants in the intronless IRf2BPL are responsible for developmental epileptic encephalopathy” (DOI: 10.1038/s41436-018-0143-0).</p></trans-abstract><kwd-group xml:lang="en"><kwd>developmental encephalopathy</kwd><kwd>epileptic encephalopathy</kwd><kwd>epilepsy</kwd><kwd>genetics</kwd><kwd>hypotonia</kwd><kwd>developmental delay</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>энцефалопатия развития</kwd><kwd>эпилептическая энцефалопатия</kwd><kwd>эпилепсия</kwd><kwd>генетика</kwd><kwd>гипотония</kwd><kwd>задержка развития</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Белоусова Е.Д., Заваденко Н.Н., Холин А.А., Шарков A.A. Новые международные классификации эпилепсий и эпилептических приступов Международной лиги по борьбе с эпилепсией (2017). Журнал неврологии и психиатрии им. С.С. Корсакова 2017;117(7):99–106. [Belousova E.D., Zavadenko N.N., Kholin A.A., Sharkov A.A. New international classifications of epilepsy and epileptic seizures of the International League Against Epilepsy (2017). Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry 2017;117(7):99–106. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Белоусова Е.Д., Заваденко Н.Н., Холин А.А., Шарков A.A. Новые международные классификации эпилепсий и эпилептических приступов Международной лиги по борьбе с эпилепсией (2017). Журнал неврологии и психиатрии им. С.С. Корсакова 2017;117(7):99–106. [Belousova E.D., Zavadenko N.N., Kholin A.A., Sharkov A.A. New international classifications of epilepsy and epileptic seizures of the International League Against Epilepsy (2017). Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry 2017;117(7):99–106. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Мухин К.Ю., Пылаева О.А. Формирование когнитивных и психических нарушений при эпилепсии: роль различных факторов, связанных с заболеваниеми лечением (обзор литературы и описания клинических случаев). Русский журнал детской неврологии 2017;3(12):7–33. [Mukhin K.Yu., Pylaeva O.A. Development of cognitive and mental disorders in epilepsy: the role of various factors associated with the disease and treatment (literature review and case reports). Russkiy zhurnal detskoy nevrologii = Russian Journal of Child Neurology 2017;12(3):7–33. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Мухин К.Ю., Пылаева О.А. Формирование когнитивных и психических нарушений при эпилепсии: роль различных факторов, связанных с заболеваниеми лечением (обзор литературы и описания клинических случаев). Русский журнал детской неврологии 2017;3(12):7–33. [Mukhin K.Yu., Pylaeva O.A. Development of cognitive and mental disorders in epilepsy: the role of various factors associated with the disease and treatment (literature review and case reports). Russkiy zhurnal detskoy nevrologii = Russian Journal of Child Neurology 2017;12(3):7–33. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Hamdan F.F., Myers C.T., Cossette P. et al. High rate of recurrent de novo mutations in developmental and epileptic encephalopathies. Am J Hum Genet 2017;101(5):664–85. DOI: 10.1016/j.ajhg.2017.09.008.</mixed-citation><mixed-citation xml:lang="ru">Hamdan F.F., Myers C.T., Cossette P. et al. High rate of recurrent de novo mutations in developmental and epileptic encephalopathies. Am J Hum Genet 2017;101(5):664–85. DOI: 10.1016/j.ajhg.2017.09.008.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Higashimori A., Dong Yu., Zhang Y. et al. Forkhead box F2 suppresses gastric cancer through a novel FOXF2-IRF2BPL-bCatenin signaling axis. Cancer Research 2018;7(78):1643–56.</mixed-citation><mixed-citation xml:lang="ru">Higashimori A., Dong Yu., Zhang Y. et al. Forkhead box F2 suppresses gastric cancer through a novel FOXF2-IRF2BPL-bCatenin signaling axis. Cancer Research 2018;7(78):1643–56.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Marcogliese P., Shashi V., Spillmann R.C. et al. Loss-of-function in IRF2BPL is associated with neurological phenotypes. BioRxiv 2018:322495.</mixed-citation><mixed-citation xml:lang="ru">Marcogliese P., Shashi V., Spillmann R.C. et al. Loss-of-function in IRF2BPL is associated with neurological phenotypes. BioRxiv 2018:322495.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. McRae J.F., Clayton S., Fitzgerald T.W. et al. Prevalence and architecture of de novo mutations in developmental disorders. Nature 2017;7642(542):433–8.</mixed-citation><mixed-citation xml:lang="ru">McRae J.F., Clayton S., Fitzgerald T.W. et al. Prevalence and architecture of de novo mutations in developmental disorders. Nature 2017;7642(542):433–8.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Scheffer I.E., Liao J. Deciphering the concepts behind “Epileptic encephalopathy” and “Developmental and epileptic encephalopathy”. Eur J Paediatr Neurol 2020;24:11–4.</mixed-citation><mixed-citation xml:lang="ru">Scheffer I.E., Liao J. Deciphering the concepts behind “Epileptic encephalopathy” and “Developmental and epileptic encephalopathy”. Eur J Paediatr Neurol 2020;24:11–4.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Skorvanek M., Dusek P., Rydzanicz M. et al. Neurodevelopmental disorder associated with IRF2BPL gene mutation: Expanding the phenotype? Parkinsonism Relat Disord 2019;62:239–41. DOI: 10.1016/j.parkreldis.2019.01.017.</mixed-citation><mixed-citation xml:lang="ru">Skorvanek M., Dusek P., Rydzanicz M. et al. Neurodevelopmental disorder associated with IRF2BPL gene mutation: Expanding the phenotype? Parkinsonism Relat Disord 2019;62:239–41. DOI: 10.1016/j.parkreldis.2019.01.017.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Tran Mau-Them F., Guibaud L., Duplomb L. et al. De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy. Genet Med 2019;4(21):1008–14.</mixed-citation><mixed-citation xml:lang="ru">Tran Mau-Them F., Guibaud L., Duplomb L. et al. De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy. Genet Med 2019;4(21):1008–14.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
